Accutane Legislation Planned; Rep. Stupak Wants Mandatory Registries
This article was originally published in The Pink Sheet Daily
Executive Summary
The registry would require participation of all patients, prescribers, and dispensers of isotretinoin. Stupak calls into question the ability of Roche and FDA to manage such a registry.